Catechins containing a galloyl moiety as potential anti-HIV-1 compounds

被引:22
|
作者
Zhao, Yali [1 ]
Jiang, Fan [1 ]
Liu, Ping [1 ]
Chen, Wei [1 ]
Yi, Kejia [2 ]
机构
[1] Chinese Peoples Liberat Army Gen Hosp, Beijing 100853, Peoples R China
[2] Beijing Sci Technol & Management Coll, Beijing, Peoples R China
关键词
GREEN TEA CATECHINS; SEMEN-MEDIATED ENHANCEMENT; EPIGALLOCATECHIN-GALLATE; HIV-1; PROTEASE; REVERSE-TRANSCRIPTASE; CD4; POLYPHENOL; BINDING; REPLICATION; METABOLISM;
D O I
10.1016/j.drudis.2012.02.015
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Catechins containing galloyl moieties are important natural antioxidant compounds. In this paper, we review the multiple mechanisms whereby catechins containing a galloyl moiety can target key proteins to inhibit sexual transmission of HIV-1, as well as HIV-1 fusion, HIV-1 reverse transcriptase, HIV-1 integrase and HIV-1 protease. Furthermore, catechins with a galloyl moiety can mediate host cell factors such as nitric oxide synthase, nuclear factor-kappa B and casein kinase II to inhibit HIV-1 infection. The most significant inhibitory effect is blocking gp120 binding to isolated human CD4(+) T cells. The multiple mechanisms underlying the anti-HIV activity of galloyl-containing catechins predict that these catechins could be used as alternative therapies in the treatment of HIV infection.
引用
收藏
页码:630 / 635
页数:6
相关论文
共 50 条
  • [21] Importance of anti-HIV-1 antibodies
    Karpas, A
    Ash, S
    Bainbridge, D
    NATURE MEDICINE, 1997, 3 (06) : 590 - 591
  • [22] Antioxidant and anti-HIV-1 integrase compounds from Smilax corbularia Kunth
    Itharat, A.
    Kejik, R.
    Tewtrakul, S.
    Watanaperomskul, C.
    PLANTA MEDICA, 2007, 73 (09) : 996 - 997
  • [23] Anti-HIV-1 gene therapy
    Medina, M
    Ramezani, A
    Joshi, S
    TRANSFUSION SCIENCE, 1996, 17 (01): : 109 - 120
  • [24] New anti-HIV-1, antimalarial, and antifungal compounds from Terminalia bellerica
    Valsaraj, R
    Pushpangadan, P
    Smitt, UW
    Adsersen, A
    Christensen, SB
    Sittie, A
    Nyman, U
    Nielsen, C
    Olsen, CE
    JOURNAL OF NATURAL PRODUCTS, 1997, 60 (07): : 739 - 742
  • [25] Flux Balance Analysis Reveals Potential Anti-HIV-1 Metabolic Targets
    Han, Runpeng
    Luo, Fei
    Yu, Haisheng
    Yan, Yajun
    Gong, Yan
    Xie, Conghua
    Cheng, Liang
    INFECTIOUS DISEASES & IMMUNITY, 2024, 4 (02): : 61 - 68
  • [26] In Silico Screening for Anti-HIV-1 Compounds Targeting to Human Cyclin T1
    Hamasaki, Takayuki
    Baba, Masanori
    ANTIVIRAL RESEARCH, 2009, 82 (02) : A24 - A24
  • [27] Computer-assisted design of dual-target anti-HIV-1 compounds
    Guimaraes, Maria C.
    Silva, Daniel G.
    da Mota, Estella G.
    da Cunha, Elaine F. F.
    Freitas, Matheus P.
    MEDICINAL CHEMISTRY RESEARCH, 2014, 23 (03) : 1548 - 1558
  • [28] Design and anti-HIV-1 activity of hammerhead and hairpin ribozymes containing a stable loop
    Koizumi, M
    Ozawa, Y
    Yagi, R
    Nishigaki, T
    Kaneko, M
    Oka, S
    Kimura, S
    Iwamoto, A
    Komatsu, Y
    Ohtsuka, E
    NUCLEOSIDES & NUCLEOTIDES, 1998, 17 (1-3): : 207 - 218
  • [29] Importance of anti-HIV-1 antibodies - Reply
    Parren, PWHI
    Sattenau, QJ
    Burton, DR
    NATURE MEDICINE, 1997, 3 (06) : 591 - 591
  • [30] Anti-HIV-1 integrase compounds from Dioscorea bulbifera and molecular docking study
    Chaniad, Prapaporn
    Wattanapiromsakul, Chatchai
    Pianwanit, Somsak
    Tewtrakul, Supinya
    PHARMACEUTICAL BIOLOGY, 2016, 54 (06) : 1077 - 1085